跳至主要内容
临床试验/NCT00895635
NCT00895635已完成3 期

Exercise Training to Reduce Claudication: Arm Ergometry Versus Treadmill Walking

University of Minnesota2 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2009年1月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
104
试验地点
2
主要终点
Maximal walking distance

研究概览

简要总结

Peripheral arterial disease (PAD) is a disorder that affects more than 8 million people in the United States. As a result of decreased blood flow to the legs, people with PAD may experience leg pain and difficulty with walking. This study will examine the effectiveness of two exercise programs-a treadmill walking program and an aerobic arm exercise program-at increasing walking distance and decreasing leg pain in people with PAD.

详细描述

PAD is a condition that occurs when atherosclerotic plaque builds up in the peripheral arteries and restricts blood flow. People with PAD often experience reduced blood flow to the legs, which may cause painful leg cramping while walking, known as intermittent claudication. Claudication affects over 4 million people in the United States, and many people with this condition can walk only ½ to 2 blocks before leg pain begins to occur. Regular treadmill walking has been shown to be effective at increasing walking distance and reducing claudication in people with PAD. However, walking on a treadmill may prove difficult for some people with PAD and usually causes increased leg pain, both of which may reduce exercise frequency. Aerobic arm exercises do not cause leg pain and may be an effective way for people with PAD to improve overall cardiovascular fitness and increase the amount of exercise they do. The purpose of this study is to compare the effectiveness of a treadmill exercise program and an aerobic arm exercise program at reducing symptoms of claudication and improving walking ability in people with PAD.

This study will enroll people with PAD and claudication. At a baseline study visit, participants will complete a treadmill walking test; a blood collection; and questionnaires to assess walking status, daily activity levels, quality of life, and mood. One week after the baseline visit, participants will attend a study visit for an assessment of forearm and leg muscle blood flow and a hand-bike test that will measure upper body strength using an arm cycle ergometer. The ergometer is a device with bicycle pedals that people move using their arms. Participants will then be randomly assigned to either a treadmill exercise training program, an arm ergometry exercise program, or a control group.

Participants in the treadmill exercise training program will attend a supervised program at one of four study sites and exercise on a treadmill for 1 hour three times a week for 12 weeks. Participants in the arm ergometry exercise program will attend a supervised program at one of four study sites and exercise using an arm cycle ergometer (hand-bike) for 1 hour three times a week for 12 weeks. Participants in both groups will also receive written instructions about exercising on their own. Participants in the control group will continue to receive usual care from their regular doctor for the treatment of PAD and will be provided with written exercise instructions. Once a week for 12 weeks, participants in the control group will attend study visits to discuss any health problems.

All participants will be asked to monitor their daily exercise for 3 separate weeks during the 12-week period by wearing an accelerometer, which will measure and record physical activity. They will also record their exercise habits in a written diary. All participants will attend study visits on 2 separate days at Weeks 6 and 12 for repeat baseline testing.

From Weeks 12 to 24, all participants will be encouraged to continue to exercise on their own at least three times a week for 30 minutes. Every 4 weeks, study researchers will call participants to offer encouragement and answer questions. At Week 23, participants will again wear an accelerometer and keep an exercise diary for 1 week. All participants will attend a final study visit at Week 24 for repeat baseline testing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has lifestyle-limiting claudication
  • Able to walk on a treadmill at 2 mph
  • Able to perform arm ergometry exercise
  • Able to complete a 12-week exercise program

排除标准

  • Physical activities are limited for reasons other than claudication
  • Uncontrolled high blood pressure
  • Uncontrolled diabetes
  • Unstable coronary heart disease
  • Ischemic rest pain or tissue loss
  • Recent (in the 3 months before study entry) coronary or peripheral revascularization

研究组 & 干预措施

Treadmill Exercise Training

Experimental

Participants will take part in a 12-week supervised treadmill exercise training program.

干预措施: Treadmill Exercise Training (Behavioral)

Arm Ergometry Exercise Training

Experimental

Participants will take part in a 12-week supervised aerobic arm ergometry exercise training program.

干预措施: Arm Ergometry Exercise Training (Behavioral)

Usual Care Control Group

Active Comparator

Participants will receive usual care for PAD from their doctor.

干预措施: Usual Care (Behavioral)

结局指标

主要结局

Maximal walking distance

时间窗: Measured at baseline and Weeks 6, 12, and 24

Pain-free walking distance

时间窗: Measured at baseline and Weeks 6, 12, and 24

次要结局

  • Cardiovascular function(Measured at baseline and Weeks 6, 12, and 24)
  • Limb blood flow(Measured at baseline and Weeks 6, 12, and 24)
  • Quality of life(Measured at baseline and Weeks 6, 12, and 24)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验